Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial.
about
Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancerFortifying the Treatment of Prostate Cancer with Physical ActivityMechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerHormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?Physical functioning for prostate healthReview of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task forceEvidence suggesting that obesity prevention measures may improve prostate cancer outcomes using data from a prospective randomized trialProspective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancerObesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer.Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysisImpact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: meta-analysis of randomized trials.Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate CancerPrimary radiotherapy vs conservative management for localized prostate cancer--a population-based study.Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States.Cardiac and cognitive effects of androgen deprivation therapy: are they real?Combining radiation therapy and androgen deprivation for localized prostate cancer-a critical review.Cause of death in older men after the diagnosis of prostate cancer.Contemporary role of androgen deprivation therapy for prostate cancerRisk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art.Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation OncologyRandomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer.Saudi Oncology Society clinical management guidelines for prostate cancer.Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.Hormone therapy in the management of prostate cancer: evidence-based approachesCancer, comorbidities, and health-related quality of life of older adults.Management of high-risk localized prostate cancer.The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalationManagement of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology.Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer.High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?Impact of the duration of hormonal therapy following radiotherapy for localized prostate cancer.Locally advanced prostate cancer: a population-based study of treatment patternsBiological, clinical, and psychosocial correlates at the interface of cancer and aging research.Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809.The current role of androgen deprivation in patients undergoing dose-escalated external beam radiation therapy for clinically localized prostate cancer.Radiation treatment for patients with intermediate-risk prostate cancer.Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer.Tissue biomarkers for prostate cancer radiation therapy.
P2860
Q26747782-20D79BD0-389C-401D-8AFF-F37C906213F2Q26765503-872A471E-F9AC-4504-A72C-692D8539C4CEQ26766638-84A9E094-CBE7-4ABB-B4D7-7C359BAF60F3Q26801132-A5636B4D-7624-4A10-9FA3-32BE3A6D7A74Q26998875-5BAF5918-1285-4664-B282-BF9A4599E08BQ27009163-764B0A62-35F1-4243-8281-D280A993D750Q30791827-644B7810-9D91-4B3C-9380-41E87137A7B8Q33415382-259B3AF3-47AC-458E-87C6-E18B546402C8Q33594364-9A3200BE-DD19-40E7-8CB0-6E21EAB56394Q33613683-7E1076AD-3DB4-4766-83C5-23705A27EE85Q33766974-717107C8-4583-438B-B85B-A179A5DD849DQ33819775-37F3A92E-5267-4D3F-91FB-C697B93F99DDQ33919551-40C89DB9-3218-4060-8F92-849CF9667287Q33926384-98639DE9-3623-419E-AE66-E635A8C77CB0Q34111628-89267D71-D784-43F3-9FAD-24DDBE713AD6Q34171941-DB8DDE73-270F-47AE-A051-F9302496B021Q34207357-EBA6FE91-8115-4C40-849B-F35D179047E0Q34211155-6C0A99B6-0E8E-47B3-8ECE-490B4794CD14Q34366865-2A250FBE-DF69-4650-9688-519834708836Q34417815-E922BE6D-C712-4A80-BDDF-09D2795734E5Q34437308-55698BF6-1ECA-44E4-964E-C8558CD842BCQ34505196-0859BC11-3989-4279-A94D-9D7389C97C6CQ34734425-74442F3A-CB28-4804-8153-F68AFA7F6BB5Q34997355-E2A4E741-5D3A-41EA-B8F9-D135357EB4BCQ35022837-B514A33A-790C-4676-BFC3-97DD5567FF8DQ35076432-9E90ADC0-EEDF-4E6A-A4B9-4984C23983C4Q35125168-8E84DEBA-413D-415C-B4DC-96A732781FD3Q35503645-70B9021F-90F7-4A37-8EC6-47389235BFC9Q35605924-4FF58803-D89E-4326-B38E-9EB301860DBCQ35673265-06EEEBFA-3ACE-44BB-AB62-5E9B088BEA7DQ35689824-C70D34B2-EF8F-40ED-8BE4-A2381E98BDE0Q35775237-6C2C820A-D36A-480D-B775-DDDF94B99535Q35803832-0377F0DE-EE5E-45D9-B1D1-8474FB3D48A2Q35850867-BAA927E2-A035-40D1-A9CB-69BBED2AAF5CQ35894352-6C1ACD5F-E31D-471D-B773-934C2E539665Q35917240-994ABAE6-623B-448D-A685-107308A0A6BBQ35947920-46FC7906-B157-44EE-9C3D-22250BC8A84DQ35992830-8475D041-366E-466E-8325-D7A1E8207414Q36006317-1B878789-F254-4119-9131-9286CCFCDFD8Q36141341-0F3B1AED-A060-4E58-921E-024E72BFC5D8
P2860
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Androgen suppression and radia ...... te cancer: a randomized trial.
@en
type
label
Androgen suppression and radia ...... te cancer: a randomized trial.
@en
prefLabel
Androgen suppression and radia ...... te cancer: a randomized trial.
@en
P2093
P356
P1476
Androgen suppression and radia ...... te cancer: a randomized trial.
@en
P2093
Andrew A Renshaw
Anthony V D'Amico
Marian Loffredo
Ming-Hui Chen
P304
P356
10.1001/JAMA.299.3.289
P407
P577
2008-01-01T00:00:00Z